Markus W Büchler

12PUBLICATIONS
64CO-AUTHORS
Molecular targetsDeep learningCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 01, 2026
Efficacy and Tolerability of Zenocutuzumab in Advanced NRG1 Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.

|Feb 04, 2026
Repotrectinib in NTRK fusion-positive advanced solid tumors: a phase 1/2 trial.

Benjamin Besse, Jessica J Lin, Lyudmila Bazhenova

|Aug 19, 2025
Longitudinal CE-MRI-based Siamese network with machine learning to predict tumor response in HCC after DEB-TACE.

Nan Wei, René Michael Mathy, De-Hua Chang

|Dec 05, 2024
Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial.

Daniel H Palmer, Richard Jackson, Christoph Springfeld

|Nov 03, 2023
Protocol of the IntenSify-Trial: An open-label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab-paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacy.

Nicolas Hohmann, Martin Ronald Sprick, Moritz Pohl

|May 11, 2023
Refining the Treatment of Pancreatic Cancer From Big Data to Improved Individual Survival.

Peter Bailey, Xu Zhou, Jingyu An

Pageof 2

Frequent Collaborators

7 joint publications

John P Neoptolemos

3 joint publications

Peter Bailey

3 joint publications

Christoph W Michalski

2 joint publications

Teresa Peccerella